Last Updated: May 10, 2026

Drugs in MeSH Category Adrenergic alpha-1 Receptor Antagonists


✉ Email this page to a colleague

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hibrow Hlthcare LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 207863-001 Feb 4, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075646-001 Oct 18, 2000 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pliva DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075750-003 Jun 8, 2001 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Pharms LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 207743-001 Sep 19, 2017 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Unichem DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 212329-004 Jan 10, 2024 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rising LABETALOL HYDROCHLORIDE labetalol hydrochloride INJECTABLE;INJECTION 075524-001 Nov 29, 1999 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.